KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Change in Cash (2019 - 2025)

Hims & Hers Health's Change in Cash history spans 7 years, with the latest figure at -$117.2 million for Q4 2025.

  • For Q4 2025, Change in Cash fell 312.77% year-over-year to -$117.2 million; the TTM value through Dec 2025 reached $7.2 million, down 94.21%, while the annual FY2025 figure was $7.2 million, 94.21% down from the prior year.
  • Change in Cash for Q4 2025 was -$117.2 million at Hims & Hers Health, up from -$779.2 million in the prior quarter.
  • Across five years, Change in Cash topped out at $850.0 million in Q2 2025 and bottomed at -$779.2 million in Q3 2025.
  • The 5-year median for Change in Cash is $7.8 million (2021), against an average of $10.0 million.
  • The largest YoY upside for Change in Cash was 3433.09% in 2025 against a maximum downside of 2251.04% in 2025.
  • A 5-year view of Change in Cash shows it stood at $7.0 million in 2021, then tumbled by 259.61% to -$11.2 million in 2022, then surged by 445.49% to $38.7 million in 2023, then surged by 42.41% to $55.1 million in 2024, then tumbled by 312.77% to -$117.2 million in 2025.
  • Per Business Quant, the three most recent readings for HIMS's Change in Cash are -$117.2 million (Q4 2025), -$779.2 million (Q3 2025), and $850.0 million (Q2 2025).